Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2023
Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious ComplicationsDaniela Weber, Andreas Hiergeist, Markus Weber, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2021
Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell TransplantationElisabeth Meedt, Andreas Hiergeist, André Gessner, et al.European Journal of Immunology|August 24, 2017
A20 deletion in T cells modulates acute graft-versus-host disease in miceJulius C Fischer, Vera Otten, Katja Steiger, et al.International Journal of Radiation Oncology, Biology, Physics|December 4, 2018
Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon SignalingJulius C Fischer, Chia-Ching Lin, Simon Heidegger, et al.European Journal of Immunology|March 16, 2017
Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in miceTobias Haas, Simon Heidegger, Alexander Wintges, et al.Science (New York, N.Y.)|October 14, 2006
5'-Triphosphate RNA is the ligand for RIG-IVeit Hornung, Jana Ellegast, Sarah Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotidesBernd Jahrsdorfer, Lars Mühlenhoff, Sue E Blackwell, et al.Nature|April 3, 2009
Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defenceOlaf Gross, Hendrik Poeck, Michael Bscheider, et al.Ebiomedicine|March 11, 2019
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockadeSimon Heidegger, Diana Kreppel, Michael Bscheider, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7Carole Bourquin, Laura Schmidt, Anna-Lisa Lanz, et al.Pageof 9